semaglutide elisa cross-reactivity glp-1 liraglutide Pharmacokinetics and brain distribution of the therapeutic peptide by a novel LC–MS/MS analysis 36) in Heparin Plasma Oral GLP-1-Based Therapeutics in the

Projections by JPMorgan suggest this number could triple by 2030, meaning up to 10% of Canadian adults could be on such medications within five years

In a randomized controlled trial that included 109 healthy men with mildly elevated cholesterol levels, 150 mg of aronia polyphenols daily for 90 days reduced total and LDL-cholesterol levels in men under 40 years of age, but not those 40 years and older, and had no effects on measures of glucose metabolism, blood pressure, oxidative stress, or inflammation

Pricing for other providers referenced is based on publicly published rates as of April 2026

The transport of fat into the mitochondria is aided by L-carnitine

10.1039/c5fo01611h Food Funct

Recent Findings Several monotherapy trials for GLP-RA and SGLT2 inhibitors have shown positive weight loss reductions along with hemoglobin A1c reductions (HbA1c) and other metabolic parameters